National Cancer Center — Gyeonggi-do

Public research footprint of National Cancer Center, compiled from the ClinicalTrials.gov public registry.

139

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · NSCLC (Advanced Non-small Cell Lung Cancer) · Non-Muscle Invasive Bladder Neoplasms

Recently updated registry entries

NCT06881784 — Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301) (Recruiting)
NCT07413939 — RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People… (Recruiting)
NCT04589845 — Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at National Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.